Fourteen years in resistanceLIVERMORE, David M.International journal of antimicrobial agents (Print). 2012, Vol 39, Num 4, pp 283-294, issn 0924-8579, 12 p.Article

Tigecycline : what is it, and where should it be used?LIVERMORE, David M.Journal of antimicrobial chemotherapy (Print). 2005, Vol 56, Num 4, pp 611-614, issn 0305-7453, 4 p.Article

Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: Our worst nightmare?LIVERMORE, David M.Clinical infectious diseases. 2002, Vol 34, Num 5, pp 634-640, issn 1058-4838Article

Minimising antibiotic resistanceLIVERMORE, David M.Lancet. Infectious diseases (print). 2005, Vol 5, Num 7, pp 450-459, issn 1473-3099, 10 p.Article

Of Pseudomonas, porins, pumps and carbapenemsLIVERMORE, David M.Journal of antimicrobial chemotherapy (Print). 2001, Vol 47, Num 3, pp 247-250, issn 0305-7453Article

EnterobacteriaceaeDENTON, Miles.International journal of antimicrobial agents. 2007, Vol 29, issn 0924-8579, S9-S22, SUP3Article

Carbapenemases : a problem in waiting ? : AntimicrobialsLIVERMORE, David M; WOODFORD, Neil.Current opinion in microbiology. 2000, Vol 3, Num 5, pp 489-495, issn 1369-5274Article

Doripenem versus Pseudomonas aeruginosa in vitro: Activity against characterized isolates, mutants, and transconjugants and resistance selection potentialMUSHTAQ, Shazad; YIGONG GE; LIVERMORE, David M et al.Antimicrobial agents and chemotherapy. 2004, Vol 48, Num 8, pp 3086-3092, issn 0066-4804, 7 p.Article

Characterization of OXA-25, OXA-26, and OXA-27, molecular class D β-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumanniiAFZAL-SHAH, Mariya; WOODFORD, Neil; LIVERMORE, David M et al.Antimicrobial agents and chemotherapy. 2001, Vol 45, Num 2, pp 583-588, issn 0066-4804Article

Carbapenem antibiotics for serious infectionsHAWKEY, Peter M; LIVERMORE, David M.BMJ (Overseas and retired doctors ed.). 2012, Vol 344, Num 7863, pp 43-47, issn 1759-2151, 5 p.Article

Activity of the anti-MRSA carbapenem razupenem (PTZ601) against Enterobacteriaceae with defined resistance mechanismsLIVERMORE, David M; MUSHTAQ, Shazad; WARNER, Marina et al.Journal of antimicrobial chemotherapy (Print). 2009, Vol 64, Num 2, pp 330-335, issn 0305-7453, 6 p.Article

Bacterial resistance: Origins, epidemiology, and impactLIVERMORE, David M.Clinical infectious diseases. 2003, Vol 36, pp S11-S23, issn 1058-4838, SUP1Article

Has the era of untreatable infections arrived?LIVERMORE, David M.Journal of antimicrobial chemotherapy (Print). 2009, Vol 64, issn 0305-7453, i29-i36, SUP1Conference Paper

In vitro activity of a novel oxazolidinone, AZD2563, against randomly selected and multiresistant Gram-positive cocciJOHNSON, Alan P; WARNER, Marina; LIVERMORE, David M et al.Journal of antimicrobial chemotherapy (Print). 2002, Vol 50, Num 1, pp 89-93, issn 0305-7453Article

Temocillin revivedLIVERMORE, David M; TULKENS, Paul M.Journal of antimicrobial chemotherapy (Print). 2009, Vol 63, Num 2, pp 243-245, issn 0305-7453, 3 p.Article

Activity of moxifloxacin and other quinolones against pneumococci resistant to first-line agents, or with high-level ciprofloxacin resistanceJOHNSON, Alan P; WARNER, Marina; LIVERMORE, David M et al.International journal of antimicrobial agents. 2001, Vol 17, Num 5, pp 377-381, issn 0924-8579Article

Detection of β-lactamase-mediated resistanceLIVERMORE, David M; BROWN, Derek F. J.Journal of antimicrobial chemotherapy (Print). 2001, Vol 48, pp 59-64, issn 0305-7453, SUP1Article

Proposed disc zone breakpoints for doripenem for use with the BSAC disc susceptibility testing methodHOPE, Russell; PLLANA, Teresa; WARNER, Marina et al.Journal of antimicrobial chemotherapy (Print). 2010, Vol 65, Num 7, pp 1547-1548, issn 0305-7453, 2 p.Article

Activity of cephalosporin CXA-101 (FR264205) against Pseudomonas aeruginosa and Burkholderia cepacia group strains and isolatesLIVERMORE, David M; MUSHTAQ, Shazad; YIGONG GE et al.International journal of antimicrobial agents (Print). 2009, Vol 34, Num 5, pp 402-406, issn 0924-8579, 5 p.Article

Properties and potential of ertapenemLIVERMORE, David M; SEFTON, Armine M; SCOTT, Geoffrey M et al.Journal of antimicrobial chemotherapy (Print). 2003, Vol 52, Num 3, pp 331-344, issn 0305-7453, 14 p.Article

Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UKDOUMITH, Michel; ELLINGTON, Matthew J; LIVERMORE, David M et al.Journal of antimicrobial chemotherapy (Print). 2009, Vol 63, Num 4, pp 659-667, issn 0305-7453, 9 p.Article

Calcium-supplemented daptomycin Etest strips for susceptibility testing on Iso-Sensitest agarJOHNSON, Alan P; MUSHTAQ, Shazad; WARNER, Marina et al.Journal of antimicrobial chemotherapy (Print). 2004, Vol 53, Num 5, pp 860-862, issn 0305-7453, 3 p.Article

Klebsiella pneumoniae isolate from South Africa with multiple TEM, SHV and AmpC β-lactamasesESSACK, Sabiha Y; HALL, Lucinda M. C; LIVERMORE, David M et al.International journal of antimicrobial agents. 2004, Vol 23, Num 4, pp 398-400, issn 0924-8579, 3 p.Article

Activity of oxazolidinone TR-700 against linezolid-susceptible and -resistant staphylococci and enterococciLIVERMORE, David M; MUSHTAQ, Shazad; WARNER, Marina et al.Journal of antimicrobial chemotherapy (Print). 2009, Vol 63, Num 4, pp 713-715, issn 0305-7453, 3 p.Article

Strategies to overcome extended-spectrum β-lactamases (ESBLs) and AmpC β-lactamases in shigellaeLIVERMORE, David M; MUSHTAQ, Shazad; NGUYEN, Tue et al.International journal of antimicrobial agents (Print). 2011, Vol 37, Num 5, pp 405-409, issn 0924-8579, 5 p.Article